CAR-T cells can accurately bind to target cells, activate cytotoxic T lymphocytes through signal transduction, and destroy tumor cells directly or indirectly by releasing perforin and granulase, activating the Fas-FasL pathway, and secreting cytokines [33]. The gene discussed is FAS; the disease is neoplasm.